Yissum - Research Development Company of the Hebrew University

Research & Services | Interactions of Pathogenic Bacteria with Infected Host

Posted by Yissum - Research Development Company of the Hebrew UniversityResponsive · Research Services and Capabilities · Israel

Summary of the technology

Research & Services | Interactions of Pathogenic Bacteria with Infected Host
Project ID : 34-2010-2419

Description of the technology

Biological/physical interactions of pathogenic bacteria, especially mechanism of protein injection

Categories

Life Sciences and Biotechnology, Medicine

Ilan Rosenshine’s Lab (IRL), Department of Microbiology and Molecular Genetics, The Institute for Medical Research Israel-Canada IMRIC, Faculty of Medicine

Research Capabilities

Research in the lab is focused on identifying bacterial proteins that subvert the function of the host cell, particularly of the immune system. We also study how these proteins can be used for therapy. We also investigate how the bacteria deliver these proteins into mammalian cells and how this system can be used as a new drug-delivery system. The bacterial injection system itself can be used as a target for antibiotic development

Advantages

We already have identified four anti-inflammatory proteins. These finding and others related to the usage of these proteins to block inflammation is now in a process of patenting.A unique research capability is a novel high-throughput system for real-time analysis of protein injection into cells by the bacteria. Additional expertise includes genetic manipulations and of pathogenic bacteria and engineering of non-virulent strains.

Research Background

We have a strong program aiming at the identification and usage of anti-inflammatory proteins and other proteins that interferes with signal transduction in mammalian cells and thus might have therapeutically value. A second program that we have is focusing on bacterial mechanism of protein injection into the infected host cell and in using this system for effective delivery of beneficial proteins into intestinal cells with the ultimate goal of developing new type of probiotic bacteria.

Researcher and Research Interests

Professor Ilan Rosenshine, Chairperson, Department of Microbiology and Molecular Genetics, Faculty of Medicine. Professor Rosenshine is the Head of the Department of Microbiology and Molecular Genetics in the Faculty of Medicine’s Institute for Medical Research Israel-Canada (IMRIC). He is a microbiologist, an expert in the analysis of host-microbe interaction, the author of over seventy scientific articles, and the recipient of numerous awards including the TEVA Joshua Kolberg Prize, the Golda Meir Lecturer Award. Professor Rosenshine serves as a Fellow of the Israel Ministry of Science.

Laboratory Contact

Professor Ilan Rosenshine, Department of Microbiology and MolecularGenetics, IMRIC, Faculty of Medicine,ilanr@ekmd.huji.ac.il, Office: +972-2-675-8754, Mobile: +972-54-882-0424

Project manager

Itzik Goldwaser
VP, Head of Research Collaborations

Project researchers

Ilan Rosenshine
HUJI, School of Medicine - IMRIC
Microbiology and Molecular Genetics

Related keywords

  • Medicine, Human Health
  • Biology / Biotechnology
  • Genome Research
  • Micro- and Nanotechnology related to Biological sciences
  • Clean Industrial Technologies
  • Recombinant DNA
  • Monoclonal Antibodies and Hybridomas
  • Gene Splicing and Manufacturing Equipment
  • Other Genetic Engineering
  • Molecular design Market
  • Microbiology Market
  • Micro- and Nanotechnology related to Biological sciences
  • Biochemistry / Biophysics Market
  • Toxicology Market
  • In vitro Testing, Trials Market
  • Stem cells and biobanks
  • Cellular and Molecular Biology Market
  • Population genetics Market
  • Gene Expression, Proteom Research Market
  • Bioinformatics Market
  • Enzymology/Protein Engineering/Fermentation
  • Genetic Engineering Market
  • Clinical Medicine
  • Anatomy, Pathology, Immunology, Physiology
  • Agro and Marine biotech
  • Other Medical/Health Related
  • Therapeutic
  • Diagnostic
  • Other (uncategorised)
  • Research Collaboration
  • Life Science & Biotechnology

About Yissum - Research Development Company of the Hebrew University

Technology Transfer Office from Israel

Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. Founded in 1964 to protect and commercialize the Hebrew University’s intellectual property. Ranked among the top technology transfer companies, Yissum has registered over 8,900 patents covering 2,500 inventions; has licensed out 800 technologies and has spun-off 90 companies. Products that are based on Hebrew University technologies and were commercialized by Yissum generate today over $2 Billion in annual sales.

Send your request

By clicking "Send your request" you are signing up and accepting our Terms of Service and Privacy policy

Technology Offers on Innoget are directly posted and managed by its members as well as evaluation of requests for information. Innoget is the trusted open innovation and science network aimed at directly connect industry needs with professionals online.